Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2010
12/08/2010EP1846373B1 Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof
12/08/2010EP1781290B1 Anti-inflammatory agents
12/08/2010EP1771432B1 Non-imidazole heterocyclic compounds as histamine h3 receptor modulators
12/08/2010EP1679074B1 Therapeutic agent for keratoconjunctive disorder
12/08/2010EP1641803B3 Thienopyrimidine derivatives as potassium channel inhibitors
12/08/2010EP1628685B1 Antiviral phosphonate analogs
12/08/2010EP1596862B1 Use of palonosetron for treating post-operative nausea and vomiting
12/08/2010EP1578409B1 Use of adenosine a2a receptor antagonists for treatment or prevention of extra-pyramidal syndrome
12/08/2010EP1578351B1 Pyrrolopyridazine compounds and methods of use thereof for the treatment of proliferative disorders
12/08/2010EP1553924B1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system
12/08/2010EP1506285B1 Combinations of anti-dr5 antibodies and anti-dr4 antibodies and other therapeutic agents
12/08/2010EP1480674B1 Treatment of central nervous system damage
12/08/2010EP1383487B1 Novel use of a peptide class of compound for treating allodynia or other different types of chronic or phantom pain
12/08/2010EP1321144B1 Eye drops
12/08/2010EP1093457B1 Cytokine receptor common gamma chain like
12/08/2010EP1007017B2 Budesonide / formoterol formulation for inhalation having a poured bulk density of 0.30 to 0.36 g/ml, a process for preparing the formulation and the use thereof
12/08/2010EP0826041B1 Transforming growth factor alpha hii
12/08/2010EP0772619B2 Immunomodulatory oligonucleotides
12/08/2010CN1993113B Particles comprising a core of calcium phosphate nanoparticles, a biomolecule and a bile acid, methods of manufacturing, therapeutic use thereof
12/08/2010CN1990482B Flavanonol compounds and their production method and use
12/08/2010CN1984644B Stabilised supersaturated solid solutions of steroidal drugs
12/08/2010CN1981739B Esmolol preparation
12/08/2010CN1977837B Application of monoesters of probucol for the treatment of cardiovascular and inflammatory disease
12/08/2010CN1969992B Pharmaceutical composition for treating acne and application method thereof
12/08/2010CN1968715B Polymeric coupling agents and pharmaceutically-active polymers made therefrom
12/08/2010CN1968704B Topical cromolyn formulations
12/08/2010CN1965849B Composition extracted from Chinese medicinals for treating coronary heart disease and method for preparing ingredients thereof
12/08/2010CN1964638B Synergism of GOS and polyfructose
12/08/2010CN1960995B Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
12/08/2010CN1960733B Combination product comprising SRC kinase inhibitor AZD0530 and an antioestrogen or EGFR-TK-inhibitor
12/08/2010CN1953743B Topical co-enzyme Q10 formulations and methods of use
12/08/2010CN1950380B (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
12/08/2010CN1946411B Inhibition of biogenic sulfide production via biocide and metabolic inhibitor combination
12/08/2010CN1946382B Rapid dissolution formulation of a calcium receptor-active compound
12/08/2010CN1938034B ED-71 preparation
12/08/2010CN1933856B Cream-gel containing ivermectin
12/08/2010CN1929840B 8-hydroxy-5- [(-hydroxy-2- [[ (1R)-2-(4-methoxyphenyl)-1-methylethyl] amino ][ethyl -2(1H)-quinolinone monohydrochloride in crystalline form and the process for its preparation
12/08/2010CN1929834B Indol-1-yl-acetic acid derivatives
12/08/2010CN1927197B Medical use of 1beta-keto-5, 11(13)-diene eudesmane-12-acid for inhibiting hepatitis B virus
12/08/2010CN1897952B Neutrophilia inhibitor
12/08/2010CN1882570B Quinazoline derivatives
12/08/2010CN1864688B Agent for preventing and treating glaucoma
12/08/2010CN1853644B Treatment and prophylaxis of diseases and infections pigs and poultry
12/08/2010CN1850271B Medicinal composition for treating neurasthenia or somatic form disorders
12/08/2010CN1836665B Pharmaceutical uses of hesperidin or its composition
12/08/2010CN1829504B Amino acid composition and supplementary liquid containing the same
12/08/2010CN1824061B Application of a combination for preparing medicine and food dual purpose nutrient for preventing true myopia
12/08/2010CN1821243B Substituted pyridine M1 receptor excitomotor, its preparing process and its use
12/08/2010CN1812796B Aivlosin for the treatment of disease due to brachyspira pilosicoli or ornithobacterium rhinotracheale
12/08/2010CN1803837B Neurotrophic growth factor
12/08/2010CN1778294B Butin and its derivative and its use in preparation of pigmental metabolic disease medicine
12/08/2010CN1762357B Oral medicinal formulation of moxifloxacin and its preparation method
12/08/2010CN1759118B Diazepinoindole derivatives as kinase inhibitors
12/08/2010CN1756527B Regulation of mammalian hair growth
12/08/2010CN1753680B Derivatives of prostaglandins for treating abdominal discomfort
12/08/2010CN1698611B Nanometer vauqueline liposome and preparation method thereof
12/08/2010CN1691954B Extraction of pharmaceutically active cannabinoids from plant materials
12/08/2010CN1679596B Dispersive composition of noncrystal Adifuwei ester and supplementary and preparation thereof
12/08/2010CN1671696B Kinase inhibitors
12/08/2010CN1660184B Combination of medicaiton containing extractive of herb of glabrous sarcandra, and preparation method and application
12/08/2010CN1646174B Controllably degradable polymeric biomolecule or drug carrier and method of synthesizing said carrier
12/08/2010CN1620453B Thiazolidinedione derivative and its use as antidiabetic
12/08/2010CN1594355B Cyclovirobuxinum D crystal, its mono-methanol crystal, and preparation and use thereof
12/08/2010CN1530102B Medical preparation containing alpha-thioctan, ambroxol and/or ACE inhibiting agent and its use in treating neurodegenerative diseases
12/08/2010CN1496741B Method for producing enteric nutrient containing malt ketose
12/08/2010CN1434681B Method for maintaining or improving the synthesis of mucins
12/08/2010CN1430513B Topical formulations for the transdermal delivery of niacin and method of treating hyperlipidemia
12/08/2010CN101910274A Amphiphilic block copolymer micelle composition containing taxane and manufacturing process of the same
12/08/2010CN101910192A 19-nor-steroid derivatives with a 15alpha,16alpha-methylene group and a saturated 17,17-spirolactone ring, use thereof, and medicaments containing said derivatives
12/08/2010CN101910191A 15,16-methylene-17-hydroxy-19-nor-21-carboxylic acid gamma-lactone derivative, use thereof, and medicament containing said derivative
12/08/2010CN101910190A 17-hydroxy-19-nor-21-carboxylic acid-steroid gamma-lactone derivative, use thereof, and medicament containing the derivative
12/08/2010CN101910189A Monosebacate of pyrazole derivative
12/08/2010CN101910184A Solubilized thiazolopyridines
12/08/2010CN101910182A Antitumor agent
12/08/2010CN101910179A (e)-n-{3- [1-(8-fluoro-11h-10-oxa-1-aza-dibenzo [a,d] cycl0hepten-5ylidene)-propyl]-phenyl }-methynsulfon amide as glucocorticoid receptor modulator for the treatment of rheumatoid
12/08/2010CN101910177A Macrocyclic indoles as hepatitis c virus inhibitors
12/08/2010CN101910176A Derivatives of N-phenyl-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910175A N-phenyl-imidazo[1,2-a]pyridine-2-carboxamide compounds, preparation thereof and therapeutic application thereof
12/08/2010CN101910174A 2-benzoylimidazo[1,2-a]pyridine derivates, preparation thereof and therapeutic use thereof
12/08/2010CN101910173A Derivatives of 2-heteroaroyl-imidazol[1,2-a] pyridine, preparation thereof and therapeutic application thereof
12/08/2010CN101910172A Derivatives of n-heterocyclic-imidazo[1,2-a]pyridine-2-carboxamides, preparation thereof and therapeutic application thereof
12/08/2010CN101910171A Nonsteroidal compounds useful as modulators of glucocorticoid receptor AP-1 and/or NF-kappa B activity and use thereof
12/08/2010CN101910170A (1,4-diaza-bicyclo[3.2.2]non-6-en-4-yl)-heterocyclyl-methanone ligands for nicotinic acetylcholine receptors, useful for the treatment of disease
12/08/2010CN101910169A Bicycloamine derivative
12/08/2010CN101910168A Tropane compounds
12/08/2010CN101910167A Heterocyclic ether and thioether derivatives and methods of use thereof
12/08/2010CN101910166A Heterocyclic derivatives as modulators of ion channels
12/08/2010CN101910165A Thiazole derivatives as protein kinase inhibitors
12/08/2010CN101910164A Diamido thiazole derivatives as protein kinase inhibitors
12/08/2010CN101910163A Heterocyclic urea and thiourea derivatives and methods of use thereof
12/08/2010CN101910162A Cyclic pyridyl-N-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals
12/08/2010CN101910160A Isoxazole derivatives as modulators of 11-beta-hydroxysteroid dehydrogenase type 1
12/08/2010CN101910159A Process for production of heterocycle-substituted pyridine derivative
12/08/2010CN101910158A Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
12/08/2010CN101910157A Indole compounds and methods for treating visceral pain
12/08/2010CN101910156A Solid forms of 3-(6-(1-(2,2-difluorobenzo[d][1,3] dioxol-5-yl) cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid
12/08/2010CN101910155A Biphenyl derivatives as modulators of the histamine-H3 receptor useful for the treatment of disorders related thereto
12/08/2010CN101910153A Pyrimidines as kinase inhibitors
12/08/2010CN101910152A 4-pyrazolyl-N-arylpyrimidin-2-amines and 4-pyrazolyl-N-heteroarylpyrimidin-2-amines as janus kinase inhibitors
12/08/2010CN101910151A Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119